Suppr超能文献

下丘脑释放因子组合对腺垂体的多重刺激。

Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors.

作者信息

Wehrenberg W B, Baird A, Ying S Y, Rivier C, Ling N, Guillemin R

出版信息

Endocrinology. 1984 Jun;114(6):1995-2001. doi: 10.1210/endo-114-6-1995.

Abstract

We have investigated the in vitro and in vivo interactions of the four hypothalamic releasing factors, LHRH, corticotropin-releasing factor, TRH, and GH-releasing factor on anterior pituitary hormone secretions, using a 2 X 2 X 2 X 2 factorial experimental design. This experimental design allows for the evaluation of both the main treatment effects of the hypothalamic releasing factors as well as all of the possible interactions between them. Significant main treatment effects were: LHRH on LH and FSH, corticotropin-releasing factor on ACTH and beta-endorphin, TRH on TSH, and GH-releasing factor on GH. These results confirm the specificity of the four releasing factors on their respective target cells. There were no significant interactions between any of the releasing factors on anterior pituitary hormone secretions. These results suggest that the changes in pituitary secretion that are observed under physiological conditions are not due to interactions between the hypothalamic releasing factors at the level of the pituitary, but rather to other secondary interactions that modify pituitary activation or response. These results also indicate that the clinical pituitary reserve tests can be expanded to include all four hypothalamic releasing factors, since any lack of response will reflect a specific pituitary defect and not a failure to respond owing to interaction of the secretagogues administered.

摘要

我们采用2×2×2×2析因实验设计,研究了四种下丘脑释放因子,即促黄体生成素释放激素(LHRH)、促肾上腺皮质激素释放因子、促甲状腺激素释放激素(TRH)和生长激素释放因子,在体外和体内对垂体前叶激素分泌的相互作用。这种实验设计能够评估下丘脑释放因子的主要治疗效果以及它们之间所有可能的相互作用。显著的主要治疗效果如下:LHRH对促黄体生成素(LH)和促卵泡生成素(FSH)有作用,促肾上腺皮质激素释放因子对促肾上腺皮质激素(ACTH)和β-内啡肽有作用,TRH对促甲状腺激素(TSH)有作用,生长激素释放因子对生长激素(GH)有作用。这些结果证实了这四种释放因子对其各自靶细胞的特异性。在垂体前叶激素分泌方面,任何一种释放因子之间均无显著相互作用。这些结果表明,在生理条件下观察到的垂体分泌变化并非由于下丘脑释放因子在垂体水平的相互作用,而是由于其他改变垂体激活或反应的次级相互作用。这些结果还表明,临床垂体储备试验可以扩展到包括所有四种下丘脑释放因子,因为任何无反应都将反映特定的垂体缺陷,而不是由于所给予的促分泌剂相互作用导致的无反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验